Liver disease in the elderly

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 1, 2002, Pages 149-158

  Jansen, Peter L M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alcoholic liver disease; Cholestatic liver disease; Elderly; Gallstones; Hepatocellular carcinoma; Liver function; Liver transplantation; Non alcoholic steatohepatitis; Old age; Viral hepatitis

Indexed keywords

AMITRIPTYLINE; CLOFIBRATE; COLLAGEN; INTERFERON; LAMIVUDINE; METFORMIN; MORPHINE; PROPRANOLOL; THEOPHYLLINE; URSODEOXYCHOLIC ACID; VERAPAMIL; HEPATITIS A VACCINE; RIBAVIRIN;

AEROBIC METABOLISM; AGING; ALCOHOL LIVER DISEASE; BILE DUCT; CHOLECYSTECTOMY; CHOLESTATIC HEPATITIS; COMMON BILE DUCT STONE; DISEASE ASSOCIATION; DRUG CLEARANCE; DRUG METABOLISM; ENDOSCOPIC SURGERY; FATTY LIVER; FENESTRATION; GALLSTONE; HEPATITIS B; HEPATITIS C; HUMAN; KUPFFER CELL; LACTIC ACIDOSIS; LIVER BLOOD FLOW; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LIVER SINUSOID; LIVER TRANSPLANTATION; LIVER WEIGHT; MORBIDITY; PREVALENCE; REVIEW; SEX DIFFERENCE; SUBENDOTHELIUM; SURVIVAL; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS HEPATITIS; LIVER CLEARANCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; AGED; CHOLELITHIASIS; LIVER; LIVER TUMOR; PATHOPHYSIOLOGY;

AGED; AGING; CARCINOMA, HEPATOCELLULAR; CHOLELITHIASIS; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 0036480658     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0271     Document Type: Article

References (63)

1. Wynne, H A, Cope, L H, Mutch, E et al. (1989). The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology, 9 297-301.
2. Zoli, M, Magalotti, D, Bianchi, G et al. (1999). Total and functional hepatic blood flow decrease in parallel with ageing. Age and Ageing, 28 29-33.
3. Marchesini, G, Bua, V, Brunori, A et al. (1988). Galactose elimination capacity and liver volume in aging man. Hepatology, 8 1079-1083.
4. Popper, H (1986). Aging and the liver. Progress in Liver Disease, 8 659-683.
5. Le Couteur, D G, & McLean, A J (1998). The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clinical Pharmacokinetics, 34 359-373.
6. Williams, D, & Woodhouse, K (1996). Age-related changes in O-deethylase and aldrin epoxidase activity in mouse skin and liver microsomes. Age and Ageing, 25 377-380.
7. Wynne, H, Mutch, E, James, O F, Rawlins, M D, & Woodhouse, K W (1987). The effect of age on mono-oxygenase enzyme kinetics in rat liver microsomes. Age and Ageing, 16 153-158.
8. Le Couteur, D G, Cogger, V C, Markus, A M et al. (2001). Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology, 33 537-543.
9. Brouwer, A, Horan, M A, Barelds, R J, & Knook, D L (1986). Cellular aging of the reticuloendothelial system. Archives of Gerontology and Geriatrics, 5 317-324.
10. Brouwer, A, Barelds, R J, & Knook, D L (1985). Age-related changes in the endocytic capacity of rat liver Kupffer and endothelial cells. Hepatology, 5 362-366.
11. Bayon, L G, Izquierdo, M A, Sirovich, I et al. (1996). Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology, 23 1224-1231.
12. Rushfeldt, C, Sveinbjornsson, B, Seljelid, R, & Smedsrod, B (1999). Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. Journal of Surgical Research, 82 209-215.
13. Sanz, N, Diez-Fernandez, C, Alvarez, A M, Fernandez-Simon, L, & Cascales, M (1999). Age-related changes on parameters of experimentally-induced liver injury and regeneration. Toxicology and Applied Pharmacology, 154 40-49.
14. Schmucker, D L (1998). Aging and the liver: an update. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 53 B315-B320.
15. Wynne, H A, Yelland, C, Cope, L H et al. (1993). The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide. Age and Ageing, 22 354-359.
16. Wynne, H A, Cope, L H, Herd, B et al. (1990). The association of age and frailty with paracetamol conjugation in man. Age and Ageing, 19 419-424.
17. Larrey, D (2000). Drug-induced liver diseases. Journal of Hepatology, 32 77-88.
18. Kiyosawa, K, Sodeyama, T, Tanaka, E et al. (1990). Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology, 12 671-675.
19. Chien, N T, Dundoo, G, Horani, M H et al. (1999). Seroprevalence of viral hepatitis in an older nursing home population. Journal of the American Geriatrics Society, 47 1110-1113.
20. Deuffic, S, Buffat, L, Poynard, T, & Valleron, A J (1999). Modeling the hepatitis C virus epidemic in France. Hepatology, 29 1596-1601.
21. Schalm, S W, Weiland, O, Hansen, B E et al. (1999). Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Gastroenterology, 117 408-413.
22. Poynard, T, Bedossa, P, Chevallier, M et al. (1995). A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. New England Journal of Medicine, 332 1457-1462.
23. Sugauchi, F, Mizokami, M, Orito, E et al. (2000). Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis. Journal of Medical Virology, 62 456-462.
24. Beutels, M, Van Damme, P, Vranckx, R, & Meheus, A (1998). The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterologica Belgica, 61 4-7.
25. Fagan, E A, & Williams, R (1990). Fulminant viral hepatitis. British Medical Bulletin, 46 462-480.
26. Hoofnagle, J H, Carithers, R L, Shapiro, C, & Ascher, N (1995). Fulminant hepatic failure: summary of a workshop. Hepatology, 21 240-252.
27. Johnson, I (2000). Alcohol problems in old age: a review of recent epidemiological research. International Journal of Geriatric Psychiatry, 15 575-581.
28. Weyerer, S, Schaufele, M, & Zimber, A (1999). Alcohol problems among residents in old age homes in the city of Mannheim, Germany. Australian and New Zealand Journal of Psychiatry, 33 825-830.
29. Wynne, H A, Wood, P, Herd, B et al. (1992). The association of age with the activity of alcohol dehydrogenase in human liver. Age and Ageing, 21 417-420.
30. Day, C P (2000). Who gets alcoholic liver disease: nature or nurture?. Journal of the Royal College of Physicians, London, 34 557-562.
31. Harris, D R, Gonin, R, Alter, H J et al. (2001). The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of Internal Medicine, 134 120-124.
32. Seeff, L B, Hollinger, F B, Alter, H J, Wright, E C, Cain, C M, Buskell, Z J et al. (2001). Long-term mortality and morbidity of transfusion-associated non-A, non- B, and type C hepatitis. Hepatology, 33 455-463.
33. Maher, J (2001). The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis. Hepatology, 33 311-312.
34. Leclercq, I A, Farrell, G C, Field, J et al. (2000). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. Journal of Clinical Investigation, 105 1067-1075.
35. Weltman, M D, Farrell, G C, Hall, P, Ingelman-Sundberg, M, & Liddle, C (1998). Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology, 27 128-133.
36. Laurin, J, Lindor, K D, Crippin, J S et al. (1996). Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology, 23 1464-1467.
37. Houwerzijl, E J, Snoek, W J, van Haastert, M, & Holman, N D (2000). [Severe lactic acidosis due to metformin therapy in a patient with contra-indications for metformin]. Nederlands Tijdschrift voor Geneeskunde, 144 1923-1926.
38. Luyckx, F H, Lefebvre, P J, & Scheen, A J (2000). Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes and Metabolism, 26 98-106.
39. Newton, J L, Jones, D E, Metcalf, J V et al. (2000). Presentation and mortality of primary biliary cirrhosis in older patients. Age and Ageing, 29 305-309.
40. Ponsioen, C Y, Lam, K, van Milligen de Wit, A W, Huibregtse, K, & Tytgat, G N (1999). Four years experience with short term stenting in primary sclerosing cholangitis. American Journal of Gastroenterology, 94 2403-2407.
41. El Serag, H B, & Mason, A C (2000). Risk factors for the rising rates of primary liver cancer in the United States. Archives of Internal Medicine, 160 3227-3230.
42. El Serag, H B, & Mason, A C (1999). Rising incidence of hepatocellular carcinoma in the United States. New England Journal of Medicine, 340 745-750.
43. El Serag, H B, Mason, A C, & Key, C (2001). Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology, 33 62-65.
44. Ono, Y, Yoshimasu, T, Ashikaga, R et al. (2000). Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. American Journal of Clinical Oncology, 23 564-568.
45. Curley, S A, Izzo, F, Ellis, L M, Nicolas, V J, & Vallone, P (2000). Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Annals of Surgery, 232 381-391.
46. Llovet, J M, Sala, M, & Bruix, J (2000). Nonsurgical treatment of hepatocellular carcinoma. Liver Transplantation, 6 (supplement 2) S11-S15.
47. Llovet, J M, Bruix, J, & Gores, G J (2000). Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology, 31 1019-1021.
48. Llovet, J M, Fuster, J, & Bruix, J (1999). Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 30 1434-1440.
49. Hanazaki, K, Kajikawa, S, & Shimozawa, N (2001). Hepatic resection for hepatocellular carcinoma in the elderly. Journal of the American College of Surgeons, 192 38-46.
50. Lui, W Y, Chau, G Y, Wu, C W, & King, K L (1999). Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology, 46 640-645.
51. Suarez, Y, Franca, A C, Llovet, J M, Fuster, J, & Bruix, J (2000). The current status of liver transplantation for primary hepatic malignancy. Clinical Liver Disease, 4 591-605.
52. Llovet, J M, & Bruix, J (2000). Early diagnosis and treatment of hepatocellular carcinoma. Baillière's Best Practice and Research Clinical Gastroenterology, 14 991-1008.
53. Harnois, D M, Steers, J, Andrews, J C et al. (1999). Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transplantation and Surgery, 5 192-199.
54. Majno, P E, Sarasin, F P, Mentha, G, & Hadengue, A (2000). Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology, 31 899-906.
55. Zetterman, R K, Belle, S H, Hoofnagle, J H et al. (1998). Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation, 66 500-506.
56. Collins, B H, Pirsch, J D, Becker, Y T et al. (2000). Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation, 70 780-783.
57. Jain, A, Reyes, J, Kashyap, R et al. (1998). Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplantation Proceedings, 30 1403-1404.
58. Levy, M F, Somasundar, P S, Jennings, L W et al. (2001). The elderly liver transplant recipient: a call for caution. Annals of Surgery, 233 107-113.
59. Barbara, L, Sama, C, Morselli, Labate M. et al. (1987). A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology, 7 913-917.
60. Lirussi, F, Nassuato, G, Passera, D et al. (1999). Gallstone disease in an elderly population: the Silea study. European Journal of Gastroenterology and Hepatology, 11 485-491.
61. Attili, A F, Capocaccia, R, Carulli, N et al. (1997). Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology, 26 809-818.
62. Rajan, M, Wali, J P, Sharma, M P, Dhar, A, & Aggarwal, P (2000). Ultrasonographic assessment of gall bladder kinetics in the elderly. Indian Journal of Gastroenterology, 19 158-160.
63. Saito, M, Tsuyuguchi, T, Yamaguchi, T, Ishihara, T, & Saisho, H (2000). Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Gastrointestinal Endoscopy, 51 540-545.